Clinical Trials

Accrual Status
Limit to SWOG Trials

654 Results

Active Filters

Closed
Phase
Accrual
32%
Published
SWOG Clinical Trial Number
S1701

A Randomized Phase II trial of Carboplatin-Paclitaxel with or without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma

Status Notes
Permanent Closure - Effective 09/29/2022
Research Committee(s)
Lung Cancer
Activated
08-09-2018
Closed
10-15-2022
ClinicalTrials.gov Registry Number
03694002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1512

A Phase II Study of PD-1 Blockade with Pembrolizumab In Patients with Locally Advanced and Metastatic Desmoplastic Melanoma (DM)

Status Notes
This study will permanently close to accrual, effective 6/4/21.
Research Committee(s)
Melanoma
Activated
10-20-2016
Closed
06-04-2021
ClinicalTrials.gov Registry Number
NCT #02775851
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1416

Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer (TNBC) and/or BRCA Mutation-Associated Breast Cancer, with or without Brain Metastases

Status Notes
S1416 is closed to accrual and treatment effective 12/31/2024.
Research Committee(s)
Breast Cancer
Activated
07-07-2016
Closed
06-15-2019
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S1403

A Randomized Phase II Trial of Afatinib Plus Cetuximab Versus Afatinib Alone In Treatment-Naïve Patients With Advanced, EGFR Mutation Positive Non-Small Lung Cancer (NSCLC)

Status Notes
This study permanently closed to accrual effective April 23, 2018.
Research Committee(s)
Lung Cancer
Activated
03-25-2015
Closed
04-23-2018
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1202

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer

Status Notes
This protocol will be permanently closed to accrual effective 10/1/15.
Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Activated
05-15-2013
Closed
10-01-2015
ClinicalTrials.gov Registry Number
NCT01598298
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1216
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1211

A Randomized Phase I/II Study of Optimal Induction Therapy of Bortezomib, Dexamethasone and Lenalidomide with or without Elotuzumab (NSC-764479) for Newly Diagnosed High Risk Multiple Myeloma (HRMM)

Status Notes
This study was temporarily closed to accrual on June 2, 2016 at 11:59 p.m. Pacific.
Research Committee(s)
Myeloma
Activated
10-12-2012
Closed
05-15-2018
ClinicalTrials.gov Registry Number
NCT01668719
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1115

Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

Research Committee(s)
Gastrointestinal Cancer
Activated
08-15-2012
Closed
05-15-2014
ClinicalTrials.gov Registry Number
NCT01658943
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0927

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III

Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Activated
02-01-2012
Closed
02-01-2013
ClinicalTrials.gov Registry Number
NCT01385137
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1119

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination

Research Committee(s)
Prevention, Screening, and Surveillance
Activated
12-02-2011
Closed
08-05-2013
ClinicalTrials.gov Registry Number
NCT01512875
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma

Research Committee(s)
Lymphoma
Activated
10-28-2011
Closed
06-06-2013
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
S1014

Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II.

Research Committee(s)
Genitourinary Cancer
Activated
08-09-2011
Closed
08-01-2013
ClinicalTrials.gov Registry Number
NCT01309672
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0931

EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.

Status Notes
Published 3/20/2024.
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2011
Closed
09-15-2016
ClinicalTrials.gov Registry Number
NCT01120249
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1005

A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
01-01-2011
Closed
05-01-2013
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0925

A Randomized Phase II Study of Androgen Deprivation Combined with IMC-A12 Versus Androgen Deprivation Alone for Patients with New Hormone-Sensitive Metastatic Prostate Cancer

Research Committee(s)
Genitourinary Cancer
Activated
12-15-2010
Closed
12-01-2012
ClinicalTrials.gov Registry Number
NCT01120236
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0806

A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL)

Research Committee(s)
Lymphoma
Activated
11-15-2010
Closed
10-01-2013
ClinicalTrials.gov Registry Number
NCT00972478
Closed
Phase
Accrual
45%
Published
SWOG Clinical Trial Number
S0933

Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma

Research Committee(s)
Melanoma
Activated
10-28-2010
Closed
11-15-2011
ClinicalTrials.gov Registry Number
NCT01120275
Closed
Phase
Accrual
100%
Published